Trials for new drugs are being carried on all the time which gives hope to those with progressive, and incurable diseases.
Today I was sent a link to The New Scientist which reports on a new drug working well with some late stage sufferers of Parkinson’s disease.
The results of a small trial of 12 patients has been presented at the Neuroscience Meeting 2015 in Chicago this weekend, which seem too good to be true.
“We’ve seen patients at end stages of the disease coming back to life,” says Charbel Moussa of Georgetown University Medical Center in Washington DC, who led the trial.
One of the patients, Alan Hoffman who was diagnosed in 1997, says:
the nilotinib trial changed his life. As his disease worsened, he had many falls, needed his wife’s help to get out of bed and he considered taking his own life. While deep brain stimulation helped treat the rigidity of his body, it wasn’t a cure, so he enrolled in the nilotinib trial. Within a matter of weeks, he was able to make the bed, and read a book for the first time in years.
Further bigger trials are called for by experts in the field.
In the meantime
Sadly, the effect doesn’t last, and when the volunteers were taken off the drug at the end of the trial, they started to deteriorate again …. Many have since tried to get hold of the drug themselves, but it costs a whopping $10,000 a month.
Only time will tell.